Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Quality in Sport

The wheel of microbiome rises, and it falls: the role and results of microbiome transplantation and the recent reports
  • Home
  • /
  • The wheel of microbiome rises, and it falls: the role and results of microbiome transplantation and the recent reports
  1. Home /
  2. Archives /
  3. Vol. 15 (2024) /
  4. Medical Sciences

The wheel of microbiome rises, and it falls

the role and results of microbiome transplantation and the recent reports

Authors

  • Joanna Kołodziej Military institute of Medicine – National Research Institute, Szaserów 128, 04-141 Warsaw, Poland https://orcid.org/0000-0002-1881-6812
  • Paulina Krzemińska Provincial Polyclinical Hospital in Płock of Marcin Kacprzak, Medyczna 19, 09–400 Płock https://orcid.org/0009-0003-6071-4320

DOI:

https://doi.org/10.12775/QS.2024.15.53020

Keywords

intestinal microbiota, eubiosis, dysbiosis, immune-stimulating bacteria, faecal microbiota transplantation, immune-mediated disease

Abstract

Intoduction: The gut microbiome plays a significant role in maintaining gastrointestinal health. Microbiota therapies involving fecal product transplantation from healthy donors, for patients with mild to moderate forms have shown significant potential to induce improvement and remission in patients suffering from inflammatory bowel disease and Clostridioides difficileinfection. There is growing interest in modulating the gut microbiome with probiotics, prebiotics and microbiota products. The undergoing rapid development over the past decade, while it is encountering some regulations related to the safety use of this method. The following paper describes and analyzes the conclusions that can be drawn from research on microbiota therapies. Methods: The review was based on the analysis of materials collected in the “Pubmed”, “Google Scholar”, “ResearchGate”, using the mentioned below keywords. State of knowledge: Disorders of the intestinal microflora, have serious consequences in the functioning of the gastrointestinal tract and the intestinal barrier, which in turn can lead to metabolic disorders, autoimmune or neurological diseases. Therefore, from the point of view of physicians, it is crucial to learn new methods of identifying the intestinal microflora in each person and to learn techniques for its restoration. Summary: Therefore, from the point of view of physicians of various specialties, it is so important to learn new methods of identifying the intestinal microflora in each person and to learn techniques for its restoration, which can be the basis for treatment or support of the main therapy of many diseases. For many patients who do not respond sufficiently to the therapies used so far, they are the hope for improving therapeutic options, used combination with immunomodulatory drugs to raise the ceiling of their efficacy or as complementary treatment.

References

Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486(7402): 207–214, doi: 10.1038/nature11234.

Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006; 124(4): 837–848, doi: 10.1016/j.cell.2006.02.017.

Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005; 308(5728): 1635–1638, doi: 10.1126/science.1110591.

Mroczyńska M, Libudzisz Z, Gałęcka M, et al. Human intestinal microorganisms and their metabolic activity. Gastroenterology Review. 2016; 4: 218–224.

Rowland I, Gibson G, Heinken A, et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr. 2018; 57(1):1-24. doi: 10.1007/s00394-017-1445-8.

Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017; 474(11):1823-1836. doi: 10.1042/BCJ20160510.

Farzaneh S, Marzieh D, Shokoufeh H, et al. Reappraisal of probiotics’ safety in human, Food and Chemical Toxicology. 2019; 129: 22-29; https://doi.org/10.1016/j.fct.2019.04.032.

Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011; 334(6052): 105–108, doi: 10.1126/science.1208344.

Biswas V, Praveen A, Marisetti AL, et al. A Mechanistic Overview on Impact of Dietary Fibres on Gut Microbiota and Its Association with Colon Cancer. Dietetics. 2022; 1(3):182-202. https://doi.org/10.3390/dietetics1030017

Otaru N, Ye K, Mujezinovic D, et al. GABA Production by Human Intestinal Bacteroides spp.: Prevalence, Regulation, and Role in Acid Stress Tolerance. Front Microbiol. 2021; 12:656895. doi: 10.3389/fmicb.2021.656895.

Bartnicka A, Gałęcka M, Mazela J. Influence of prenatal and postnatal factors on the gut microbiota of newborns. Med Stand Ped. 2016; 13:112–116.

Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA. 2010; 107(26):11971–11975, doi: 10.1073/pnas.1002601107,

Keag OE, Norman JE, Stock SJ. Long-term risks and benefits associated with cesarean delivery for mother, baby, and subsequent pregnancies: Systematic review and meta-analysis. PLoS Med. 2018; 15(1):e1002494. doi: 10.1371/journal.pmed.1002494.

Darabi B, Rahmati S, Hafezi MR. et al. The association between caesarean section and childhood asthma: an updated systematic review and meta-analysis. Allergy, Asthma &Clin Immunol. 2019; 15: 62

Saravanan P; Diabetes in Pregnancy Working Group; Maternal Medicine Clinical Study Group; Royal College of Obstetricians and Gynaecologists, UK. Gestational diabetes: opportunities for improving maternal and child health. Lancet Diabetes Endocrinol. 2020; 8(9):793-800. doi: 10.1016/S2213-8587(20)30161-3

Gałęcka M, Bartnicka A, Szewc M, et al. Formation of gut microbiota in infants a prerequisite for maintaining health. 2016; 13: 359–367.

Li L, Li X, Zhong W, et al. Gut microbiota from colorectal cancer patients enhances the progression of intestinal adenoma in Apcmin/+mice. eBioMedicine part of the Lancet Discovery Science, 48; 301-315, 2019; doi: https://doi.org/10.1016/j.ebiom.2019.09.021

Gurung M, Li Z, You H, et al. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine part of the Lancet Discovery Science, 2020; 51:102590 doi: https://doi.org/10.1016/j.ebiom.2019.11.051

Konturek PC, Koziel J, Dieterich W, et al. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation. J Physiol Pharmacol. 2016; 67(6):859-866. PMID: 28195066.

Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011; 53: 994–1002.

Baktash A, Terveer EM, Zwittink RD, et al. Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections. Front. Microbiol. 2018; 9:1242. doi: 10.3389/fmicb.2018.01242

Green JE, Davis JA, Berk M, et al. Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis. Gut Microbes. 2020; 12(1):1-25. doi: 10.1080/19490976.2020.1854640.

Kelly CR, Kahn S, Kashyap P, et al. Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology 2015; 149: 223-237.

Soveral LF, Korczaguin GG, Schmidt PS, et al. Immunological mechanisms of fecal microbiota transplantation in recurrent Clostridioides difficile infection. World J Gastroenterol. 2022; 28(33):4762-4772. doi: 10.3748/wjg.v28.i33.4762.

Rokkas T, Gisbert JP, Gasbarrini A, et al. A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection. United European Gastroenterol J. 2019; 7(8):1051-1063. doi: 10.1177/2050640619854587.

Van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. New England J of Med. 2013; 368(5), 407-415.

Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett. 2009; 294(1): 1–8, doi: 10.1111/j.1574-6968.2009.01514.x.

Kump P, Högenauer C. Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases? Dig Dis. 2016; 34 Suppl 1:74-81. doi: 10.1159/000447379.

Marrs T, Walter J. Pros and cons: Is faecal microbiota transplantation a safe and efficient treatment option for gut dysbiosis? Allergy. 2021; 76(7), 2312-2317.

Paramsothy S, Kamm M, Kaakoush N, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. The Lancet. 2017; 389(10075), 1218-1228.

Ghouri YA, Tahan V, Shen B. Secondary causes of inflammatory bowel diseases. World J Gastroenterol. 2020; 26(28):3998-4017. doi: 10.3748/wjg.v26.i28.3998.

Khoruts A, Rank KM, Newman KM, et al. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. Clin Gastroenterol Hepatol. 2016; 14(10):1433-8. doi: 10.1016/j.cgh.2016.02.018.

Qazi T, Amaratunga T, Barnes EL, et al. The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis. Gut Mic. 2017; 8(6):574-588. doi: 10.1080/19490976.2017.1353848.

Romano S, Savva GM, Bedarf JR. et al. Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation. npj Parkinsons Dis. 2021; 7, 27. https://doi.org/10.1038/s41531-021-00156-z

Tan AH, Chuah KH, Beh YY, et al. Gastrointestinal Dysfunction in Parkinson's Disease: Neuro-Gastroenterology Perspectives on a Multifaceted Problem. J Mov Disord. 2023; 16(2):138-151. doi: 10.14802/jmd.22220.

Scheperjans F, Aho V, Pereira PAB, et al. Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord. 2015; 30(3): 350–358, doi: 10.1002/mds.26069.

Minato T, Maeda T, Fujisawa Y, et al. Progression of Parkinson’s disease is associated with gut dysbiosis: two-year follow-up study. PLoS One. 2017; 12(11): e0187307, doi: 10.1371/journal. pone.0187307.

Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA. 2011; 108(38): 16050–16055, doi: 10.1073/pnas.1102999108.

Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009; 457: 480–484.

Duncan SH, Lobley GE, Holtrop G, et al. Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. 2008; 32: 1720–1724

Halkjær SI, Lo B, Cold F, et al. Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. World J Gastroenterol. 2023; 29(20):3185-3202. doi: 10.3748/wjg.v29.i20.3185.

Yang Y, Yan J, Li S, et al. Efficacy of fecal microbiota transplantation in type 2 diabetes mellitus: a systematic review and meta-analysis. Endocrine. 2024; 84(1):48-62. doi: 10.1007/s12020-023-03606-1.

Bethlehem L, Estevinho MM, Grinspan A, et al. Microbiota therapeutics for inflammatory bowel disease: the way forward. Lancet Gastroenterol Hepatol. 2024; 9(5):476-486. doi: 10.1016/S2468-1253(23)00441-7.

Fairlie T, Shah A, Talley NJ, et al. Overlap of disorders of gut-brain interaction: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023; 8(7):646-659. doi: 10.1016/S2468-1253(23)00102-4.

Zhang F, Cui B. Fecal microbiota transplantation: understanding from holistic integrative view Ame med journ. 2018; 3. doi: 10.21037/amj.2017.11.13

Lewis A. Merde: excursions in scientific, cultural, and socio-historical coprology. New York, NY: Random House, 1999.

Ok Kim K, Gluck M. Fecal microbiota transplantation: an update on clinical practice. Clinical Endoscopy. 2019;52(2):137-143. doi: https://doi.org/10.5946/ce.2019.009

Kellermayer R. Fecal microbiota transplantation: great potential with many challenges. Translational gastroenterology and hepatology 2019; 4. doi: 10.21037/tgh.2019.05.10

Chen LA, Boyle K. The Role of the Gut Microbiome in Health and Disease in the Elderly. Curr Gastroenterol Rep. 2024; https://doi.org/10.1007/s11894-024-00932-w.

Parker A, Romano S, Ansorge R, et al. Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain. Microbiome. 2022; 10(1):68. https://doi.org/10.1186/s40168-022-01243-w.

Downloads

  • PDF

Published

2024-07-29

How to Cite

1.
KOŁODZIEJ, Joanna and KRZEMIŃSKA, Paulina. The wheel of microbiome rises, and it falls: the role and results of microbiome transplantation and the recent reports. Quality in Sport. Online. 29 July 2024. Vol. 15, p. 53020. [Accessed 28 June 2025]. DOI 10.12775/QS.2024.15.53020.
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 15 (2024)

Section

Medical Sciences

License

Copyright (c) 2024 Joanna Kołodziej, Paulina Krzemińska

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Stats

Number of views and downloads: 190
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

intestinal microbiota, eubiosis, dysbiosis, immune-stimulating bacteria, faecal microbiota transplantation, immune-mediated disease
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop